Meeting history 2004-2005

Brief account of the NSI activities between the Annual General Meetings in 2004 and 2005.

For more recent NSI meeting history, click here.

NSI's Annual General Meeting 2005

Date: November 18th

Download (pdf):

Minutes from NSI's Annual General Assembly 2005
(18 members were present at the beginning of the general assembly)

Final agenda for the General Assembly, with Annual Report for 2005

Scientific programme
(approx. 80 persons were present at the main lecture, and 40-50 stayed to listen to the remaining oral presentations)

Minutes from NSI's Annual General Meeting 2005

Order: Printed copy of the abstract book

Invited speaker: Guttorm Haraldsen, MD, PhD

LIIPAT - Laboratory for Immunohistochemistry and Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway

Title: Endothelial cell activation in inflammation and immunity

Download: abstract

Web: www.med.uio.no/rh/patologi/liipat/endothelium

See also articles: Pubmed

	MHC class II association with lipid rafts modulates T cell activation Paul Roche, PhD Principal Investigator Paul Roche Laboratory, Experimental Immunology Branch, National Cancer Institute Date: October 12, 2005 Download: abstract See also articles: PubMed
	Joint Meeting 36th Annual Meeting of the DGfI and the SSI Date: September 21-24, 2005 Venue: Christian-Albrechts-Universität, Kiel, Germany Web: www.uni-kiel.de/immunologie/DGfI/2005
	TLR-dependent and TLR-independent Immunoadjuvant Pathways: The Detection of Antigens Presented in the Context of Cell Death Professor Bruce Beutler Department of Immunology, The Scripps Research Institute Date: September 8, 2005 Download: abstract See also articles: PubMed
	Bruce Beutler is a pioneer in finding both dominant and recessive mutations that cause alteration or impairment of normal immune function. His work established that the Toll-like receptors (TLRs) serve as the key sensors used by the mammals to perceive infection. This conclusion rested upon the positional cloning of a mutation (Lps) that prevented mice from sensing bacterial lipopolysaccharide [Poltorak et al., Science 282:2085-2088 (1998)]. Since that time, he has established many of the essential proteins that are active in TLR signal transduction. Dr Beutler has recently identified a novel TLR-independent immunoadjuvant pathway which is driven by programmed cell death. This finding may have a major impact on our understanding on how adaptive immune responses are triggered. Bruce Beutler is professor at The Scripps Research Institute, La Jolla, CA, USA. Selected References Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B. (2005). CD36 is a sensor of diacylglycerides. Nature 433:523-7 Beutler,B. (2004). Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257-263. Hoebe,K., Jannsen,E.M., Kim,S.O., Alexopoulou,L., Flavell,R.A., Han,J., and Beutler,B. (2003). Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways . Nature Immunology 4, 1223-1229.
	Studies of infectious diseases in an endemic area: Immunology research at the Armauer Hansen Research Institute (AHRI), Ethiopia Dr Abraham Aseffa Date: August 30, 2005 Download: abstract See also articles: PubMed Organized by: The NSI, the Faculty of Medicine (Univ of Oslo), and the GLOBINF network
	NKG2 receptors and IL-15: a dialog between CTL and tissue targets Bana Jabri, MD, PhD Assistant Professor, Department of Pathology, University of Chicago Date: August 23, 2005 Download: abstract Web: http://immunology.uchicago.edu/faculty/jabri.html See also articles: PubMed Organized by: The NSI, and the Faculty of Medicine, University of Oslo
	IL-15 and coeliac disease Nadine Cerf-Bensussan, MD, PhD Research director INSERM, Faculté Necker, Paris Chief of INSERM unit EMI-0212: Interactions between the intestinal epithelium and the immune system Date: June 16, 2005 Download: Abstract See also articles: PubMed
	Immunotherapy of Lymphoma Professor Ronald Levy, MD, PhD Chief, Division of Oncology, Stanford University School of Medicine Date: June 13, 2005 Download: Abstract Web: http://med.stanford.edu/profiles/Ronald_Levy See also articles: PubMed Organized by: The NSI, and the Faculty of Medicine, University of Oslo
	Ron Levy is a pioneer in development of immunotherapy in the treatment of B cell lymphomas. He has made seminal contributions to passive immunotherapy of B lymphomas by use of anti-CD20 mAb (Rituximab). He has over many years developed active immunization with monoclonal antibody produced by B lymphomas [so called idiotype (Id) vaccination]. Ron Levy is professor of Medicine and Chief of Division of Oncology at Stanford University. The seminar should be of interest to immunologists, hematologists and oncologists.
	The gut-joint axis: clinically relevant? The 9th Annual Broegelmann Lecture 2005 Professor Per Brandtzæg Date: May 20, 2005
	Regulatory T cells and the concept of Th1 and Th2 cells Dr. Carsten B. Schmidt-Weber, PhD Head of Molecular Immunology at SIAF, Davos, Switzerland Date: May 19, 2005 Download: Abstract Web: Swiss Institute of Allergy and Asthma Research (SIAF) See also articles: PubMed
	Day of Immunology April 29, 2005 General info from EFIS: www.dayofimmunology.org/partners/norway The Norwegian programme (Immunologiens dag 2005) Planned activities: Popularized Immunology Conference, Oslo University Aula, April 29 Popularized Laboratory Course, Rikshospitalet (Oslo), April 28 Immunology lectures at Haukeland University Hospital (Bergen), April 29 Opening Ceremony of Bergen Research School in Inflammation (BRSI)
	Chimeric NK cell receptors for cancer immunotherapy Assistant Professor Charles L. Sentman Date: March 10, 2005 Download: Abstract Web: Dartmouth Medical School, Charles L. Sentman See also articles: PubMed Organized by: The NSI and the Immiclub teams
	Reflections on the development and 46 years work in immunology Professor Morten Harboe Date: March 8, 2005 Download: Abstract View: Presentation See also articles: PubMed
	Design and construction of new antibody derived molecules, "Pepbodies" and "Troybodies" Professor Inger Sandlie Date: January 18, 2005 Download: Abstract Se also article: Biochem Soc Trans. 2002 Aug;30(4):500-6 Se also article: Nat Rev Drug Discov. 2003 Jan;2(1):52-62
	Novel Mechanisms of Signalling by CD28 Professor Kjetil Taskén, Biotechnology Centre of Oslo, University of Oslo Date: December 2, 2004 Download: Abstract